唯赛勃(688718) - 2021 Q4 - 年度财报

Financial Performance - The company achieved a net profit attributable to shareholders of RMB 50,479,049.29 in 2021[6]. - The profit distribution plan for 2021 is to not distribute profits, which has been approved by the board of directors[6]. - The company's operating revenue for 2021 was CNY 379,186,008.35, representing a year-over-year increase of 20.92% compared to CNY 313,595,097.19 in 2020[22]. - The net profit attributable to shareholders for 2021 was CNY 50,479,049.29, which is a 7.96% increase from CNY 46,758,480.63 in 2020[22]. - The net profit after deducting non-recurring gains and losses was CNY 48,097,549.31, reflecting a 16.55% increase from CNY 41,267,768.61 in 2020[22]. - The cash flow from operating activities for 2021 was CNY 40,750,098.39, a significant decrease from CNY 91,092,991.60 in 2020[22]. - The total assets at the end of 2021 were CNY 780,518,511.86, which is a 38.22% increase from CNY 564,682,033.71 at the end of 2020[22]. - The net assets attributable to shareholders increased by 58.62% to CNY 684,326,314.04 at the end of 2021, compared to CNY 431,424,854.36 at the end of 2020[22]. - The basic earnings per share for 2021 was CNY 0.3401, down 5.21% from CNY 0.3588 in 2020[23]. - The diluted earnings per share for 2021 was also CNY 0.3401, reflecting the same decrease of 5.21% from the previous year[23]. - The weighted average return on equity for 2021 was 9.33%, a decrease of 1.81 percentage points from 11.14% in 2020[23]. Risk Management - There are no significant risks that materially affect the company's operations during the reporting period[4]. - The company has disclosed potential risks related to forward-looking statements in its report[4]. - The company has a comprehensive risk description in the management discussion and analysis section[4]. - The company has not yet achieved profitability since its listing[4]. - The company has not violated decision-making procedures for external guarantees[4]. - There are no non-operational fund occupations by controlling shareholders or related parties[4]. Research and Development - The company continued to increase R&D investment, with R&D expenses accounting for 6.27% of operating revenue, a decrease of 0.51 percentage points year-on-year[24]. - Research and development expenses amounted to 23.7789 million yuan, a year-on-year increase of 11.77%, with 41 new patents obtained during the reporting period[34]. - The company has developed a high-performance seawater desalination membrane with a target water flux greater than 30 GFD and a salt rejection rate exceeding 99.8%[74]. - The company is investing $30 million in research and development for new technologies aimed at enhancing product offerings[161]. - The company has increased its R&D personnel from 72 to 82, representing 16.87% of the total workforce, up from 14.69%[83]. Market Expansion and Sales - The company achieved operating revenue of 379.186 million yuan, an increase of 20.92% year-on-year, and a net profit attributable to shareholders of 50.479 million yuan, up 7.96% year-on-year[34]. - The company has established four regional sales centers in China to enhance domestic market promotion and brand building, optimizing market structure and customer base[35]. - The company is actively pursuing market expansion through new product development and strategic partnerships in various sectors, including seawater desalination and industrial wastewater treatment[76]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% market share by 2025[161]. - The company improved its marketing capabilities, leading to significant growth in domestic market coverage and sales revenue[110]. Governance and Compliance - The board of directors consists of 8 members, including 3 independent directors, and held 7 meetings during the reporting period[147]. - The supervisory board is composed of 3 members, including 1 employee supervisor, and convened 6 meetings in the reporting period[147]. - The company has established performance evaluation and incentive mechanisms for directors, supervisors, and senior management[148]. - The company strictly adhered to information disclosure obligations, ensuring that all disclosed information was true, accurate, complete, timely, and fair[148]. - The company has maintained a transparent and independent governance structure, with no interference from the controlling shareholder in operational decisions[149]. Financial Position and Assets - The total assets of the company increased to 3 billion, up from 2.5 billion, indicating a growth of 20% in asset value[163]. - Cash and cash equivalents at the end of the period amounted to ¥130,748,392.19, representing 16.75% of total assets, a significant increase of 628.44% compared to the previous period[126]. - Accounts receivable increased by 32.75% year-on-year to ¥82,424,457.27, reflecting the company's expanded revenue scale[127]. - Inventory increased by 32.73% year-on-year to ¥84,629,748.43, driven by rising raw material prices and expanded revenue scale[127]. - The company's fixed assets net value increased by 22.34% year-on-year to ¥199,008,681.04, due to the completion of construction projects[128]. Challenges and Risks - The company faces risks related to technological upgrades, as its competitive advantage relies on continuous innovation in high-performance membrane technology; failure to adapt could lead to a decline in market position and profitability[90]. - The company is currently developing new product lines based on long-term strategic planning, but risks include potential delays in R&D progress or failure to meet commercialization expectations[91]. - The company has a high proportion of overseas sales, which exposes it to risks from trade protectionism and geopolitical instability that could negatively impact international market demand[92]. - Rising prices of key raw materials such as fiberglass and epoxy resin have adversely affected the company's cost control and gross margin stability[92]. - The company faces financial risks related to accounts receivable, as an increase in outstanding balances could lead to potential collection issues and impact overall performance[95].